Generation of Metaphosphate Analogues
1
mixture of diastereoisomers. H NMR (400 MHz, CDCl3): δ 8.96
C6′DMT), 128.18, 128.13, and 127.9 (C2′′DMT, C3′′DMT, C5′′DMT,
(1H, b, H3), 7.61 and 7.60 (1H, 2 × q, H6, J6-CH ) 1.1 Hz),
C6′′DMT), 126.9 (C4′′DMT), 113.2 (C3DMT, C5DMT, C3′DMT, C5′DMT),
111.1 and 111.0 (C5), 86.9 (Ar3CDMT), 85.6 and 85.0 (2 × d, C4′,
J4′-P ) 6.7 Hz), 84.72 and 84.68 (C1′), 79.6 and 79.5 (2 × d,
(CH3)C, JC-P ) 9.2 Hz), ∼76.8 and 76.4 (2 × d, C3′, J3′-P ) 5.3
Hz), 64.2 and 64.1 (C5′), 55.2 (2 × OCH3), 45.5 ((CH3CH2)3NH+),
39.7 and 39.3 (2 × d, C2′, J2′-P ) 3.8 Hz), 30.22 and 30.15 (2 ×
d, (CH3)3C, JCH -P ) 4.4 Hz), 11.43 (CH3), 8.1 ((CH3CH2)3NH+).
31P NMR (1623 MHz, CDCl3): δ 51.0 and 50.7. HRMS: m/z
695.2181 ([M - H]-, C35H40N2O9PS- calcd 695.2198).
General Procedure for Oxidative Esterification of 5′-
Dimethoxytritylthymidin-3′-yl H-Phosphonothioate (2b), 5′-
Dimethoxytritylthymidin-3′-yl H-Phosphonodithioate (3a), and
5′-Dimethoxytritylthymidin-3′-yl H-Phosphonoselenoate (4a)
(All Triethylammonium Salts) with 3′-O-(tert-Butyldi-
methylsilyl)thymidine (20). To a solution of 2b,42,67 3a7 or 4a57
(0.2 mmol), 2064 (714 mg, 2 mmol), and Et3N (83 µL, 61 mg, 0.6
mmol) in THF (3 mL) was added a solution of iodine (56 mg,
0.22 mmol) in the same solvent (3 mL) dropwise, at -78 °C with
vigorous stirring. After the addition was complete, the mixture was
allowed to warm to room temperature and the solvent was
evaporated. The residue was partitioned between CH2Cl2 and 5%
aq NaHCO3 and the aqueous phase was once more extracted with
CH2Cl2. The combined organic layers were dried over Na2SO4 and
evaporated to dryness. The products were isolated by silica gel
column chromatography, using a stepwise gradient of MeOH
(0-5%) in CH2Cl2, containing 0.02% Et3N. A yield of 1.3-1.5
mmol (450-550 mg) of 3′-O-(tert-butyldimethylsilyl)thymidine 20
could be recovered during the chromatography.
3
7.32-6.77 (13H, m, DMT protons), 6.44 and 6.43 (1H, 2 × dd,
H1′, J1′-2′ ) 8.1 Hz, J1′-2′′ ) 5.3 Hz), 5.28 (1H, m, H3′), 4.36 and
4.32 (1H, 2 × m, H4′), 4.07-3.84 (2H, m, CH3CH2), 3.76 (6H, s,
2 × OCH3), 3.50 (0.5H, dd, H5′, J5′-5′′ ) 10.5 Hz, J5′-4′ ) 2.8
Hz), 3.45-3.36 (1.5H, m, H5′, H5′′), 2.97 (6H, m, (CH3CH2)3NH+,
JCH -CH ) 7.3 Hz), 2.66 (1H, m, H2′), 2.35 (1H, m, H2′′), 1.36
and2 1.33 (3H, 2 × d, CH3, JCH -6 ) 1.1 Hz), 1.28-1.21 (10.5H,
3
3
apparent t, (CH3CH2)3NH+ and CH3CH2, J(CH -CH ) NH ) 7.2 Hz),
+
3
2 3
1.14 (1.5H, CH3CH2, JCH -CH ) 7.1 Hz). 13C NMR (100 MHz,
CDCl3): δ 163.9 (C4), 1583.56 2and 158.53 (C4DMT, C4′DMT), 150.45
and 150.41 (C2), 144.33 and 144.32 (C1′′DMT), 136.75 and 135.73
(C6), 135.50, 135.47, and 135.3 (C1DMT, C1′DMT), 139.1 (C2DMT
C6DMT, C2′DMT, C6′DMT), 128.1 and 127.9 (C2′′DMT, C3′′DMT
C5′′DMT, C6′′DMT), 126.0 (C4′′DMT), 113.2 (C3DMT, C5DMT, C3′DMT
,
,
,
C5′DMT), 111.11 and 111.06 (C5), 86.9 (Ar3CDMT), 85.4 and 85.1
(2 × d, C4′, J4′-P ) 5.9 Hz), 84.62 and 84.57 (C1′), 76.6 and 76.3
(2 × d, C3′, J3′-P ) 5.5 Hz), 63.9 (C5′), 61.86 and 61.83 (2 × d,
CH3CH2, JCH-P ) 5.8 Hz), 55.2 (2 × OCH3), 45.7 ((CH3CH2)3NH+),
39.7 and 39.5 (2 × d, C2′, J2′-P ) 3.7 Hz), 16.3 and 16.2 (2 × d,
CH3CH, JCH3-P
) 5.9 Hz), 11.52 and 11.46 (CH3), 9.2
((CH3CH2)3NH+). 31P NMR (162 MHz, CDCl3): δ 57.3 and 57.1.
HRMS: m/z 667.1913 ([M - H]-, C33H36N2O9PS- calcd 667.1885).
5′-O-Dimethoxytritylthymidin-3′-yl Isopropyl Phosphorothio-
ate, Triethylammonium Salt (11c). White powder, 141 mg (90%),
1
1:1 mixture of diastereoisomers. H NMR (400 MHz, CDCl3): δ
8.79 and 8.72 (1H, 2 × s, H3), 8.01 (1H, b, (CH3CH2)3NH+), 7.63
and 7.62 (1H, 2 × q, H6, J6-CH ) 1.2 Hz), 7.43-6.79 (13H, m,
3
DMT protons), 6.46 and 6.44 (1H, 2 × dd, H1′, J1′-2′ ) 7.4 Hz,
J1′-2′′ ) 5.5 Hz), 5.28 (1H, m, H3′), 4.64 and 4.55 (1H, 2 × dsep,
3′-O-(tert-Butyldimethylsilyl)thymidin-5′-yl 5′-O-Dimetho-
xytritylthymidin-3′-yl Phosphorothioate, Triethylammonium
Salt (11e). White powder, 175 mg (81%), 1:1 mixture of diaste-
reoisomers. 1H NMR (400 MHz, CDCl3): δ 11.89 (1H, b,
(CH3CH2)3NH+), 8.90, 8.89, 8.81, and 8.73 (2H, 4 × s, H3a, H3b),
7.78, 7.77, 7.64, and 7.59 (2H, 4 × s, H6a, H6b), 7.45-6.81 (13H,
m, DMT prot.), 6.48-6.34 (2H, m, H1′a, H1′b), 5.36 (1H, m, H3′a),
4.62-4.31 (1H, 3 × m, H3′b), 4.39 and 4.31 (1H, 2 × m, H4′a),
4.19-3.88 (3H, m, H4′b H5′b, H5′′b), 3.81, 3.80, and 3.79 (6H, 3
× s, 2 × OCH3), 3.56-5.36 (2H, m, H5′a, H5′′a), 3.10 and 3.09
(6H, 2 × q, (CH3CH2)3NH+, JCH -CH ) 7.3 Hz), 2.68 and 2.56
(CH3)2CH, JCH-P ) 10.5 Hz, JCH-(CH )2 ) 6.3 Hz), 4.40 and 4.35
3
(1H, 2 × m, H4′), 3.77 (6H, s, 2 × OCH3), 3.52 (0.5H, dd, H5′,
J5′-5′′ ) 10.5 Hz, J5′-4′ ) 2.8 Hz), 3.45-3.36 (1.5H, m, H5′, H5′′),
2.91 (6H, q, (CH3CH2)3NH+, JCH
) 7.2 Hz), 2.71 and 2.67
2-CH3
(1H, 2 × ddd, H2′, J2′-2′′ ) 13.4 Hz, J2′-1′ ) 5.5 Hz, J2′-3′ ) 1.1
Hz), 2.35 (1H, m, H2′′), 1.34 and 1.33 (3H, 2 × d, CH3, JCH -6
)
1.2 Hz), 1.28 (1.5H, d, (CH3)2CH, JCH -CH ) 6.3 Hz), 1.24 3(9H,
t, (CH3CH2)3NH+, JCH -CH ) 7.2 Hz),3 ∼1.23 (1.5H, (CH3)2CH),
1.20 (1.5H, d, (CH3)23CH, JCH -CH ) 6.3 Hz), 1.12 (1.5H, d,
2
(CH3)2CH, JCH -CH ) 6.3 Hz). 13C3NMR (125 MHz, CDCl3): δ 163.6
2
3
(1H, 2 × dd, H2′a, J2′a-2′′a ) 13.3 Hz, J2′a-1′a ) 5.3 Hz), 2.43-2.10
(3H, m, H2′′a, H2′b, H2′′b), 1.98, 1.95, 1.48, and 1.39 (6H, 4 × s,
2 × CH3), 1.33 (9H, t, (CH3CH2)3NH+, JCH -CH ) 7.3 Hz), 0.90
3
(C4), 158.63 and 158.60 (C4DMT, C4′DMT), 150.22 and 150.19 (C2),
144.41 and 144.36 (C1′′DMT), 136.9 and 135.5 (C6), 135.38 and
135.34 (C1DMT, C1′DMT), 130.1 (C2DMT, C6DMT, C2′DMT, C6′DMT),
128.2 and 127.9 (C2′′DMT, C3′′DMT, C5′′DMT, C6′′DMT), 127.0
(C4′′DMT), 113.2 (C3DMT, C5DMT, C3′DMT, C5′DMT), 111.10 and
3
2
and 0.88 (9H, 2 × s, (CH3)3CSi), 0.09 and 0.06 (6H, 2× s,
(CH3)2Si). 13C NMR (100 MHz, CDCl3): δ 163.90, 163.85, 163.74,
and 163.71 (C4a, C4b), 158.69, 158.66, 158.64, and 158.58 (C4DMT
,
111.07 (C5), 87.0 (Ar3CDMT), 85.6 and 85.3 (2 × d, C4′, J4′-P
)
C4′DMT), 150.39 and 150.38 (C2a, C2b), 144.32 and 144.30
(C1′′DMT), 136.4, 135.7, 135.6, 135.5, 135.4, and 135.1 (C6a, C6b,
C1DMT, C1′DMT), 130.1 and 130.0 (C2DMT, C6DMT, C2′DMT, C6′DMT),
6.2 Hz), 84.75 and 84.71 (C1′), ∼76.6 (C3′), 70.1 and 69.9 (2 ×
d, (CH3)2CH, JCH-P ) 6.0 Hz), 64.09 and 64.03 (C5′), 55.2 (2 ×
OCH3), 45.8 ((CH3CH2)3NH+), 39.7 and 39.5 (2 × d, C2′, J2′-P
)
)
128.2, 128.1, 128.0, 127.8, and 127.7 (C2′′DMT, C3′′DMT, C5′′DMT
C6′′DMT), 127.1 and 127.0 (C4′′DMT), 113.3 and 113.1 (C3DMT
,
,
3.9 Hz), 24.1, 23.9, 23.76, and 23.73 (4 × d, (CH3)2CH, JCH -P
3
5.0 Hz), 11.49 and 11.46 (CH3), 9.5 ((CH3CH2)3NH+). 31P NMR
(202 MHz, CDCl3): δ 52.2 and 52.1. HRMS: m/z 681.1999 ([M -
H]-, C34H38N2O9PS- calcd 681.2041).
C3′DMT, C5DMT, C5′DMT), 111.3, 111.2, 111.1, and 111.0 (C5a, C5b),
87.0 and 86.9 (Ar3CODMT), 86.5, 86.4, 86.1, 85.7, 85.6, 83.3, 85.2,
85.1, 85.0, 84.9, 84.7, and 84.6 (C1′a, C1′b, C4′a, C4′b), ∼77.2
(C3′a), 72.84 and 72.80 (C3′b), 65.8 and 65.1 (d, C5′b, J5′-P ) 7.9
Hz), 64.0 and 63.9 (C5′a), 55.2 (2 × OCH3), 45.6 ((CH3CH2)3NH+),
40.9 and 40.8 (C2′b), 39.8 and 39.1 (d, C2′a, J2′-P ) 3.9 Hz), 25.7
((CH3)3CSi), 17.9 ((CH3)3CSi), 12.45, 12.39, 11.6, and 11.5 (CH3a,
CH3b), 8.6 ((CH3CH2)3NH+), -4.68, -4.71, –4.74, and -4.76
((CH3)2Si). 31P NMR (202 MHz, CDCl3): δ 57.5 and 57.3. HRMS:
m/z 977.3330 ([M - H]-, C47H58N4O13PSSi- calcd 977.3233).
3′-O-(tert-Butyldimethylsilyl)thymidin-5′-yl 5′-O-Dimetho-
xytritylthymidin-3′-yl Phosphorodithioate, Triethylammonium
tert-Butyl 5′-O-dimethoxytritylthymidin-3′-yl Phosphorothio-
ate, Triethylammonium Salt (11d). White powder, 136 mg (85%),
1
1:1 mixture of diastereoisomers. H NMR (400 MHz, CDCl3): δ
8.96 (1H, b, H3), 7.63 (1H, s, H6), 7.48-6.68 (13H, m, DMT
protons), 6.47 (1H, m, H1′), 5.33 (1H, m, H3′), 4.42 (1H, m, H4′),
3.78 (6H, s, 2 × OCH3), 3.53 (0.5H, dd, H5′, J5′-5′′ ) 10.6 Hz,
J5′-5′′ ) 2.9 Hz), 3.46 (0.5H, dd, H5′, J5′-5′′ ) 10.6 Hz, J5′-4′
)
2.3 Hz), 3.43-3.38 (1H, m, H5′′), 3.06 (6H, q, (CH3CH2)3NH+,
JCH -CH ) 7.3 Hz), 2.72 (1H, dd, H2′, J2′-2′′ ) 13.3 Hz, J2′-1′
)
3
5.62Hz), 2.36 (1H, m, H2′′), 1.50 and 1.40 (9H, 2 × s, (CH3)3C),
Salt (21). White powder, 167 mg (76%). H NMR (500 MHz,
1
1.36 and 1.34 (3H, 2 × s, CH3), 1.31 (9H, t, (CH3CH2)3NH+,
CDCl3): δ 10.29 (1H, b, (CH3CH2)3NH+), 8.56 and 8.48 (2H, 2 ×
s, H3a, H3b), 7.83 and 7.59 (2H, 2 × s, H6a, H6b), 7.43-6.88 (13H,
m, DMT prot.), 6.43 (1H, dd, H1′a, J1′a-2′a ) 8.6 Hz, J1′a-2′′a ) 5.4
Hz), 6.40 (1H, dd, H1′b, J1′b-2′b ) 7.9 Hz, J1′b-2′′b ) 6.1 Hz), 5.47
(1H, dd, H3′a, J3′a-P ) 12.5 Hz, J3′a-2′′a ) 5.8 Hz), 4.56 (1H, m,
JCH -CH ) 7.3 Hz). 13C NMR (100 MHz, CDCl3): δ 163.8 (C4),
3
158.542and 158.51 (C4DMT, C4′DMT), 150.4 and 150.3 (C2), 144.39
and 144.35 (C1′′DMT), 135.90 and 135.85 (C6), 135.57, 135.51,
135.35, and 135.31 (C1DMT, C1′DMT), 130.1 (C2DMT, C6DMT, C2′DMT
,
J. Org. Chem. Vol. 73, No. 13, 2008 5037